The ISoP PatEG-SIG for Promoting Patient Engagement in Pharmacovigilance: A Change of Paradigm is Needed

Drug Saf. 2023 Jul;46(7):619-623. doi: 10.1007/s40264-023-01313-4. Epub 2023 May 25.

Manal M Younus^{1

2}, Mayada Alkhakany^{2

3}, Priya Bahri⁴, Angela Caro⁵, Hadir Rostom^{6

7}, Helen Byomire Ndagije⁸, Mohamed A Elhawary^{9

10}

¹ Iraqi Pharmacovigilance Center, Ministry of Health, Baghdad, Iraq.
² International Society of Pharmacovigilance Patient Engagement Special Interest Group, London, UK.
³ Healthcare Affair, Boehringer Ingelheim, Dubai, United Arab Emirates.
⁴ International Society of Pharmacovigilance (ISoP)-Special Interest Group on Medicinal Product Risk Communication, European Medicines Agency, Pharmacovigilance Office, Amsterdam, The Netherlands.
⁵ International Society of Pharmacovigilance (ISoP), Pharmacy Career Director of Pontificia Universidad Javeriana, Bogotá, Colombia.
⁶ International Society of Pharmacovigilance (ISoP)-Egypt Chapter, Cairo, Egypt.
⁷ Faculty of Pharmacy, MSA University, 6th of October City, Giza, Egypt.
⁸ National Drug Authority, Directorate of Product Safety, Kampala, Uganda.
⁹ Egyptian Ministry of Health and Population, Central Administration for Pharmaceutical Affairs, Cairo, Egypt. mohamed.ahmed.elhawary19@gmail.com.
¹⁰ Faculty of Pharmacy, Ain Shams University, Cairo, Egypt. mohamed.ahmed.elhawary19@gmail.com.

No abstract available

MeSH terms